M
Mark Corbett
Researcher at University of York
Publications - 32
Citations - 10642
Mark Corbett is an academic researcher from University of York. The author has contributed to research in topics: Randomized controlled trial & Systematic review. The author has an hindex of 18, co-authored 31 publications receiving 4117 citations.
Papers
More filters
Journal ArticleDOI
RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne,Jelena Savović,Jelena Savović,Matthew J. Page,Roy G Elbers,Natalie S Blencowe,Isabelle Boutron,Isabelle Boutron,Isabelle Boutron,Christopher J Cates,Hung-Yuan Cheng,Mark Corbett,Sandra Eldridge,Jonathan Emberson,Miguel A. Hernán,Sally Hopewell,Asbjørn Hróbjartsson,Asbjørn Hróbjartsson,Daniela R Junqueira,Peter Jüni,Jamie J Kirkham,Toby J Lasserson,Tianjing Li,Alexandra McAleenan,Barnaby C Reeves,Sasha Shepperd,Ian Shrier,Lesley A. Stewart,Kate Tilling,Ian R. White,Penny Whiting,Penny Whiting,Julian P T Higgins,Julian P T Higgins +33 more
TL;DR: The Cochrane risk-of-bias tool has been updated to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
Journal ArticleDOI
Acupuncture and other physical treatments for the relief of pain due to osteoarthritis of the knee: network meta-analysis.
Mark Corbett,Stephen Rice,Vichithranie Madurasinghe,Russell Slack,Debra Fayter,Melissa Harden,Alex J. Sutton,Hugh MacPherson,Nerys Woolacott +8 more
TL;DR: Results indicate that acupuncture can be considered as one of the more effective physical treatments for alleviating osteoarthritis knee pain in the short-term, and much of the evidence in this area of research is of poor quality, meaning there is uncertainty about the efficacy of many physical treatments.
Journal ArticleDOI
Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool.
TL;DR: Assessment of trial baseline data should form a key and prominent part of selection bias judgements when using the risk of bias tool, and possible benefits are outlined, including reduced uncertainty in systematic review conclusions, reduced risk of chance findings being ascribed to treatment effects and better use of available evidence.
Journal ArticleDOI
A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin
TL;DR: Evidence of effectiveness was found for PDT in the treatment of Barrett's oesophagus, pre-cancerous skin conditions and the following cancers, but Methodological limitations and gaps in the evidence base made it difficult to draw firm conclusions.
Journal ArticleDOI
Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation
Jane Burch,Mike Paulden,Stefano Conti,Christian Stock,Mark Corbett,Nicky J Welton,A E Ades,Alex J. Sutton,Nicola J. Cooper,Alex J. Elliot,Karl G. Nicholson,Steven Duffy,Claire McKenna,Lesley A. Stewart,Marie Westwood,Stephen Palmer +15 more
TL;DR: The clinical effectiveness data for population subgroups used to inform the multiparameter evidence synthesis and cost-effectiveness modelling were, in places, limited and this should be borne in mind when interpreting the findings of this review.